Protocol Name: IMAGINE: Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients
Sponsor: Vitaeris
Indication: Post Transplant – Chronic Active Antibody Mediated Rejection
Primary Investigator: Bernard Fischbach, MD
Location: Dallas Transplant Institute, 3604 Live Oak Street, Suite 100, Dallas, TX 75204